Approval · Notice of Compliance 12608 · 2011
AVA-SUMATRIPTAN: Notice of Compliance 12608
Issued September 6, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12608
- Date
- September 6, 2011
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New Manufacturer and Product Name
- Therapeutic class
- 5-HT1 Receptor Agonist - Migraine Therapy
- Canadian reference product
- IMITREX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-SUMATRIPTAN | 02366258 | Cancelled Post Market |
| AVA-SUMATRIPTAN | 02366266 | Cancelled Post Market |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 50 MG per TAB
- SUMATRIPTAN SUCCINATE 100 MG per TAB